ALL insider files Form 144 to sell 7,383 shares valued at $1.54M
Rhea-AI Filing Summary
The Allstate Corporation filed a Form 144 notifying of a proposed sale of 7,383 common shares through Fidelity Brokerage Services, with an aggregate market value of $1,537,214.43, to be sold on 08/22/2025 on the NYSE. The securities are reported as acquired on 08/22/2025 and traceable to an option granted 02/11/2016; payment is listed as cash. The filer represents no undisclosed material adverse information about the issuer and indicates no securities sold in the past three months. This notice documents a planned insider sale consistent with Rule 144 disclosure requirements.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 reporting of a planned insider sale worth $1.54M; no past three-month sales reported.
The filing documents a proposed sale of 7,383 Allstate common shares through Fidelity on 08/22/2025 with an aggregate market value of $1,537,214.43. Acquisition details reference an option granted on 02/11/2016 and a same-day acquisition date of 08/22/2025, with payment in cash. There are no reported sales by this person in the prior three months. From a market perspective, this is a disclosure of insider liquidity rather than an operational development; the filing itself contains no financial results or new business information.
TL;DR: Compliance-focused disclosure showing adherence to Rule 144; signer attests no undisclosed material adverse information.
The Form 144 provides required transparency for an insider sale and includes the standard attestation that the seller is unaware of undisclosed material adverse information. The filing lists broker details (Fidelity Brokerage Services LLC) and the exchange (NYSE). No governance issues, litigation, or departures are disclosed. As presented, the document fulfills procedural disclosure obligations but does not indicate broader governance changes.